A new approach for clinical translation of infrared spectroscopy: exploitation of the signature of glioblastoma for general brain tumor recognition
Preprint
- 5 November 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose: Infrared (IR) spectroscopy has the potential for tumor delineation in neurosurgery. Previous research showed that IR spectra of brain tumors are generally characterized by reduced lipid-related and increased protein-related bands. Therefore, we propose the exploitation of these common spectral changes for brain tumor recognition. Methods: Attenuated total reflection IR spectroscopy was performed on fresh specimens of 790 patients within minutes after resection. Using principal component analysis and linear discriminant analysis, a classification model was developed on a subset of glioblastoma (n = 135) and non-neoplastic brain (n = 27) specimens, and then applied to classify the IR spectra of several types of brain tumors. Results: The model correctly classified 82% (517/628) of specimens as “tumor” or “non-tumor”, respectively. While the sensitivity was limited for infiltrative glioma, this approach recognized GBM (86%), other types of primary brain tumors (92%) and brain metastases (92%) with high accuracy and all non-tumor samples were correctly identified. Conclusion: The concept of differentiation of brain tumors from non-tumor brain based on a common spectroscopic tumor signature will accelerate clinical translation of infrared spectroscopy and related technologies. The surgeon could use a single instrument to detect a variety of brain tumor types intraoperatively in future clinical settings. Our data suggests that this would be associated with some risk of missing infiltrative regions or tumors, but not with the risk of removing non-tumor brain.Keywords
All Related Versions
This publication has 33 references indexed in Scilit:
- Infrared Spectroscopic Studies of Cells and Tissues: Triple Helix Proteins as a Potential Biomarker for TumorsPLOS ONE, 2013
- Screening of biochemical/histological changes associated to C6 glioma tumor development by FTIR/PCA imagingThe Analyst, 2010
- Differentiation between normal and tumor vasculature of animal and human glioma by FTIR imagingThe Analyst, 2010
- Vibrational spectroscopy: a clinical tool for cancer diagnosticsThe Analyst, 2009
- Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patientsNeuro-Oncology, 2008
- Chemical mapping of tumor progression by FT-IR imaging: towards molecular histopathologyTrends in Biotechnology, 2006
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Classification of malignant gliomas by infrared spectroscopy and linear discriminant analysisBiopolymers, 2006
- Analysis of human brain tissue, brain tumors and tumor cells by infrared spectroscopic mappingThe Analyst, 2004
- Distinguishing and grading human gliomas by IR spectroscopyBiopolymers, 2003